Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spondylarthritis | 13 | 2024 | 62 | 5.040 |
Why?
|
Spondylitis, Ankylosing | 12 | 2024 | 159 | 3.890 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 2 | 2021 | 32 | 0.890 |
Why?
|
Uveitis | 2 | 2024 | 398 | 0.860 |
Why?
|
Interleukin-23 | 3 | 2021 | 202 | 0.800 |
Why?
|
Atlanto-Axial Joint | 2 | 2019 | 60 | 0.790 |
Why?
|
Zygapophyseal Joint | 4 | 2024 | 129 | 0.750 |
Why?
|
Colitis, Ulcerative | 3 | 2021 | 1926 | 0.680 |
Why?
|
Interleukin-17 | 2 | 2016 | 924 | 0.640 |
Why?
|
Practice Guidelines as Topic | 3 | 2024 | 7454 | 0.620 |
Why?
|
Receptors, Interleukin-2 | 7 | 2005 | 564 | 0.590 |
Why?
|
Inflammatory Bowel Diseases | 6 | 2024 | 2442 | 0.580 |
Why?
|
T-Box Domain Proteins | 2 | 2021 | 472 | 0.540 |
Why?
|
Rheumatology | 4 | 2024 | 617 | 0.530 |
Why?
|
Psoriasis | 1 | 2024 | 926 | 0.510 |
Why?
|
Antirheumatic Agents | 6 | 2024 | 1381 | 0.500 |
Why?
|
Low Back Pain | 4 | 2024 | 990 | 0.480 |
Why?
|
Colon | 3 | 2021 | 1801 | 0.470 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2014 | 146 | 0.420 |
Why?
|
Arthritis, Rheumatoid | 7 | 2019 | 3781 | 0.410 |
Why?
|
Osteogenesis | 2 | 2019 | 1295 | 0.400 |
Why?
|
T-Lymphocyte Subsets | 7 | 2018 | 1816 | 0.400 |
Why?
|
Arthritis | 1 | 2016 | 684 | 0.360 |
Why?
|
L-Selectin | 4 | 2007 | 212 | 0.360 |
Why?
|
Sex Characteristics | 1 | 2021 | 2649 | 0.350 |
Why?
|
Chromosomes, Mammalian | 1 | 2011 | 148 | 0.350 |
Why?
|
T-Lymphocytes | 9 | 2015 | 10266 | 0.350 |
Why?
|
Bone Marrow Cells | 3 | 2018 | 2414 | 0.350 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2020 | 4415 | 0.320 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9540 | 0.300 |
Why?
|
Rheumatic Diseases | 1 | 2015 | 659 | 0.300 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1673 | 0.300 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2593 | 0.280 |
Why?
|
Mice, Inbred BALB C | 9 | 2021 | 6231 | 0.270 |
Why?
|
DNA-Binding Proteins | 5 | 2021 | 9617 | 0.270 |
Why?
|
Autoimmune Diseases | 2 | 2012 | 2257 | 0.250 |
Why?
|
Bone Density | 1 | 2019 | 3573 | 0.250 |
Why?
|
Dendritic Cells | 2 | 2014 | 2747 | 0.250 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5704 | 0.240 |
Why?
|
Mice | 27 | 2021 | 82049 | 0.230 |
Why?
|
B-Lymphocytes | 2 | 2015 | 4793 | 0.220 |
Why?
|
Guideline Adherence | 2 | 2024 | 2235 | 0.220 |
Why?
|
Osteoclasts | 2 | 2019 | 713 | 0.210 |
Why?
|
Quantitative Trait Loci | 1 | 2011 | 2131 | 0.210 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12795 | 0.200 |
Why?
|
Interleukin-2 | 3 | 2004 | 1895 | 0.200 |
Why?
|
Graft vs Host Disease | 5 | 2007 | 3049 | 0.200 |
Why?
|
Chondrocytes | 3 | 2018 | 800 | 0.190 |
Why?
|
Signal Transduction | 6 | 2015 | 23648 | 0.190 |
Why?
|
Osteoblasts | 2 | 2019 | 1153 | 0.190 |
Why?
|
Clonal Anergy | 1 | 2001 | 169 | 0.180 |
Why?
|
Promoter Regions, Genetic | 2 | 2020 | 5797 | 0.180 |
Why?
|
Biological Availability | 1 | 2021 | 391 | 0.180 |
Why?
|
Lipocalins | 1 | 2021 | 161 | 0.180 |
Why?
|
Animals | 31 | 2021 | 169285 | 0.180 |
Why?
|
Colitis | 4 | 2018 | 1242 | 0.180 |
Why?
|
Humans | 48 | 2024 | 768171 | 0.170 |
Why?
|
Hydrodynamics | 1 | 2021 | 167 | 0.170 |
Why?
|
Lumbar Vertebrae | 3 | 2024 | 1886 | 0.170 |
Why?
|
Joint Diseases | 1 | 2023 | 461 | 0.170 |
Why?
|
Cervical Atlas | 1 | 2019 | 22 | 0.160 |
Why?
|
Th17 Cells | 2 | 2016 | 791 | 0.160 |
Why?
|
Odontoid Process | 1 | 2019 | 46 | 0.160 |
Why?
|
Bone Marrow Transplantation | 5 | 2018 | 2709 | 0.160 |
Why?
|
Immunity, Innate | 1 | 2011 | 3080 | 0.160 |
Why?
|
Antigens, CD | 3 | 2004 | 4035 | 0.160 |
Why?
|
Congresses as Topic | 1 | 2024 | 812 | 0.160 |
Why?
|
Immune Tolerance | 2 | 2004 | 2323 | 0.160 |
Why?
|
Lymphocyte Activation | 5 | 2020 | 5505 | 0.160 |
Why?
|
Spleen | 2 | 2021 | 2296 | 0.150 |
Why?
|
Myeloid Cells | 2 | 2021 | 839 | 0.150 |
Why?
|
Mice, Knockout | 5 | 2021 | 14488 | 0.150 |
Why?
|
Injections | 1 | 2021 | 841 | 0.150 |
Why?
|
Disease Models, Animal | 10 | 2021 | 18349 | 0.150 |
Why?
|
Inflammation | 5 | 2024 | 10873 | 0.140 |
Why?
|
Th1 Cells | 2 | 2018 | 1042 | 0.130 |
Why?
|
Cytokines | 3 | 2021 | 7452 | 0.130 |
Why?
|
Spine | 1 | 2023 | 1140 | 0.130 |
Why?
|
X-Ray Microtomography | 1 | 2019 | 457 | 0.130 |
Why?
|
Nerve Block | 1 | 2023 | 716 | 0.130 |
Why?
|
Plasmids | 1 | 2021 | 2269 | 0.130 |
Why?
|
Interleukin-12 | 1 | 2018 | 577 | 0.130 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 2271 | 0.130 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1892 | 0.120 |
Why?
|
Cells, Cultured | 3 | 2021 | 19025 | 0.120 |
Why?
|
Drug Delivery Systems | 2 | 2018 | 2237 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2211 | 0.120 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 102 | 0.120 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2007 | 2171 | 0.120 |
Why?
|
Osteoarthritis | 1 | 2023 | 1072 | 0.120 |
Why?
|
Helicobacter Infections | 1 | 2018 | 390 | 0.120 |
Why?
|
Feces | 1 | 2021 | 1511 | 0.120 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11930 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 1 | 2004 | 1512 | 0.120 |
Why?
|
Monocytes | 2 | 2021 | 2605 | 0.120 |
Why?
|
HLA Antigens | 1 | 2020 | 1334 | 0.120 |
Why?
|
Calcification, Physiologic | 1 | 2015 | 170 | 0.110 |
Why?
|
Societies, Medical | 2 | 2024 | 3968 | 0.110 |
Why?
|
Ossification, Heterotopic | 1 | 2016 | 240 | 0.110 |
Why?
|
Spinal Diseases | 1 | 2019 | 561 | 0.110 |
Why?
|
Immunoconjugates | 1 | 2001 | 975 | 0.110 |
Why?
|
Osteochondrodysplasias | 1 | 2015 | 183 | 0.110 |
Why?
|
Unfolded Protein Response | 1 | 2015 | 239 | 0.110 |
Why?
|
Genetic Drift | 1 | 2012 | 41 | 0.100 |
Why?
|
Transcription Factors | 3 | 2019 | 12171 | 0.100 |
Why?
|
Skin Diseases | 1 | 2021 | 1085 | 0.100 |
Why?
|
Mice, Inbred C57BL | 8 | 2021 | 22380 | 0.100 |
Why?
|
Mice, Transgenic | 5 | 2016 | 9561 | 0.100 |
Why?
|
Autoimmunity | 1 | 2020 | 1361 | 0.100 |
Why?
|
Physical Therapy Modalities | 1 | 2015 | 533 | 0.100 |
Why?
|
Bone Diseases | 1 | 2015 | 416 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 36741 | 0.100 |
Why?
|
Genetic Vectors | 1 | 2021 | 3403 | 0.090 |
Why?
|
Protein Kinases | 1 | 2018 | 1611 | 0.090 |
Why?
|
Genetic Variation | 2 | 2020 | 6610 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20225 | 0.090 |
Why?
|
Natural Language Processing | 1 | 2020 | 1203 | 0.090 |
Why?
|
Gonadal Steroid Hormones | 1 | 2015 | 707 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2003 | 4648 | 0.090 |
Why?
|
Cartilage, Articular | 2 | 2015 | 1104 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1143 | 0.090 |
Why?
|
Biological Products | 1 | 2019 | 947 | 0.090 |
Why?
|
Chemokines | 1 | 2014 | 963 | 0.080 |
Why?
|
Male | 19 | 2024 | 364731 | 0.080 |
Why?
|
Edema | 2 | 2024 | 765 | 0.080 |
Why?
|
Cell Differentiation | 2 | 2019 | 11677 | 0.080 |
Why?
|
Gene Targeting | 1 | 2012 | 841 | 0.080 |
Why?
|
Crohn Disease | 1 | 2021 | 2295 | 0.080 |
Why?
|
Genomics | 1 | 2024 | 5926 | 0.080 |
Why?
|
Intestines | 2 | 2015 | 1909 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15949 | 0.080 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1561 | 0.080 |
Why?
|
Back Pain | 2 | 2024 | 548 | 0.080 |
Why?
|
Female | 16 | 2024 | 397187 | 0.070 |
Why?
|
Mass Screening | 1 | 2024 | 5458 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15453 | 0.070 |
Why?
|
Gene Deletion | 1 | 2015 | 2674 | 0.070 |
Why?
|
Immunologic Memory | 2 | 2018 | 1377 | 0.070 |
Why?
|
Genetic Engineering | 1 | 2012 | 936 | 0.070 |
Why?
|
Phenotype | 3 | 2021 | 16726 | 0.070 |
Why?
|
Chronic Disease | 2 | 2019 | 9384 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2023 | 4355 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 1886 | 0.060 |
Why?
|
Mycophenolic Acid | 1 | 2007 | 348 | 0.060 |
Why?
|
Integrin beta Chains | 1 | 2005 | 115 | 0.060 |
Why?
|
Isoantigens | 1 | 2007 | 562 | 0.060 |
Why?
|
Models, Biological | 1 | 2021 | 9497 | 0.060 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2015 | 1417 | 0.060 |
Why?
|
Antibodies, Monoclonal | 4 | 2007 | 9262 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3857 | 0.060 |
Why?
|
Oligonucleotides | 1 | 2007 | 563 | 0.060 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 696 | 0.060 |
Why?
|
Bone and Bones | 1 | 2015 | 2590 | 0.060 |
Why?
|
Toll-Like Receptors | 1 | 2007 | 582 | 0.060 |
Why?
|
Opportunistic Infections | 1 | 2007 | 375 | 0.060 |
Why?
|
Mice, Inbred DBA | 2 | 2002 | 624 | 0.060 |
Why?
|
Aminopeptidases | 1 | 2024 | 114 | 0.060 |
Why?
|
Tumor Necrosis Factors | 1 | 2003 | 109 | 0.060 |
Why?
|
Stem Cells | 1 | 2016 | 3538 | 0.050 |
Why?
|
Hydroxychloroquine | 1 | 2007 | 426 | 0.050 |
Why?
|
Histocompatibility | 1 | 2004 | 321 | 0.050 |
Why?
|
Interferon-alpha | 1 | 2007 | 910 | 0.050 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2024 | 303 | 0.050 |
Why?
|
Adoptive Transfer | 2 | 2002 | 825 | 0.050 |
Why?
|
Bacteria | 1 | 2014 | 2216 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2004 | 740 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 474 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 321 | 0.050 |
Why?
|
Protein Array Analysis | 1 | 2004 | 399 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 478 | 0.050 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 440 | 0.050 |
Why?
|
Receptors, Chemokine | 2 | 2002 | 652 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4887 | 0.050 |
Why?
|
Antigens | 1 | 2007 | 1443 | 0.050 |
Why?
|
Injections, Intra-Articular | 1 | 2023 | 284 | 0.050 |
Why?
|
Lumbosacral Region | 1 | 2023 | 294 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 693 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2003 | 588 | 0.050 |
Why?
|
HLA-DR3 Antigen | 1 | 2000 | 24 | 0.050 |
Why?
|
Antigen-Presenting Cells | 2 | 2001 | 960 | 0.050 |
Why?
|
Glucocorticoids | 2 | 2015 | 2167 | 0.040 |
Why?
|
HLA-B27 Antigen | 1 | 2020 | 67 | 0.040 |
Why?
|
Arthritis, Experimental | 1 | 2002 | 293 | 0.040 |
Why?
|
History, 17th Century | 1 | 2020 | 108 | 0.040 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2007 | 843 | 0.040 |
Why?
|
Cell Movement | 4 | 2005 | 5213 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2024 | 81760 | 0.040 |
Why?
|
Retroviridae | 1 | 2002 | 846 | 0.040 |
Why?
|
United States | 3 | 2024 | 73039 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 467 | 0.040 |
Why?
|
Transplantation Tolerance | 1 | 2005 | 633 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1246 | 0.040 |
Why?
|
Mice, SCID | 4 | 2002 | 2627 | 0.040 |
Why?
|
Liver Diseases | 1 | 2007 | 1305 | 0.040 |
Why?
|
Helicobacter hepaticus | 1 | 2018 | 25 | 0.040 |
Why?
|
Necrosis | 1 | 2023 | 1616 | 0.040 |
Why?
|
Autoantibodies | 1 | 2007 | 2121 | 0.040 |
Why?
|
Joints | 2 | 2016 | 324 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2002 | 1156 | 0.040 |
Why?
|
Acute Disease | 3 | 2004 | 7243 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2001 | 877 | 0.040 |
Why?
|
Radiation Chimera | 1 | 2018 | 216 | 0.040 |
Why?
|
Antigens, Differentiation | 1 | 2001 | 921 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2007 | 1596 | 0.040 |
Why?
|
Middle Aged | 7 | 2024 | 223487 | 0.040 |
Why?
|
History, 19th Century | 1 | 2020 | 714 | 0.040 |
Why?
|
Aged | 6 | 2024 | 171502 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2001 | 1344 | 0.040 |
Why?
|
Triamcinolone Acetonide | 1 | 2018 | 105 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39354 | 0.040 |
Why?
|
Alleles | 2 | 2020 | 6894 | 0.030 |
Why?
|
Drug Substitution | 1 | 2019 | 291 | 0.030 |
Why?
|
HLA-DR Antigens | 1 | 2018 | 609 | 0.030 |
Why?
|
Adult | 4 | 2024 | 223646 | 0.030 |
Why?
|
Radiography | 2 | 2019 | 6986 | 0.030 |
Why?
|
Ligaments | 1 | 2016 | 127 | 0.030 |
Why?
|
Activin Receptors, Type I | 1 | 2016 | 134 | 0.030 |
Why?
|
Area Under Curve | 1 | 2020 | 1643 | 0.030 |
Why?
|
Spondylarthropathies | 1 | 2015 | 14 | 0.030 |
Why?
|
Synovial Fluid | 1 | 2018 | 393 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20762 | 0.030 |
Why?
|
Environment | 1 | 2001 | 1121 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2016 | 422 | 0.030 |
Why?
|
Receptors, CCR7 | 2 | 2007 | 105 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2000 | 977 | 0.030 |
Why?
|
Synovial Membrane | 2 | 1999 | 536 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1353 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4206 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2020 | 937 | 0.030 |
Why?
|
History, 21st Century | 1 | 2020 | 1573 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 59626 | 0.030 |
Why?
|
Growth Plate | 1 | 2015 | 276 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1997 | 1252 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3782 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2005 | 3409 | 0.020 |
Why?
|
Hydrogels | 1 | 2018 | 744 | 0.020 |
Why?
|
History, 20th Century | 1 | 2020 | 2766 | 0.020 |
Why?
|
Macrophages | 2 | 2018 | 5802 | 0.020 |
Why?
|
Transplantation, Homologous | 3 | 2007 | 4834 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2016 | 846 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 18065 | 0.020 |
Why?
|
Bone Resorption | 1 | 2015 | 728 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2018 | 10478 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2003 | 4939 | 0.020 |
Why?
|
Genetic Loci | 1 | 2020 | 2629 | 0.020 |
Why?
|
Interleukin-6 | 2 | 1999 | 3229 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3115 | 0.020 |
Why?
|
Ligands | 1 | 2016 | 3284 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2018 | 1703 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26379 | 0.020 |
Why?
|
Kinetics | 2 | 2007 | 6330 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1810 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5099 | 0.020 |
Why?
|
Dexamethasone | 1 | 2015 | 1965 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2002 | 3447 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2575 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2005 | 5717 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15602 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12466 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2337 | 0.020 |
Why?
|
Knee Joint | 1 | 1994 | 1683 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 16044 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10590 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14729 | 0.010 |
Why?
|
Mesentery | 1 | 2005 | 202 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2015 | 3044 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2004 | 205 | 0.010 |
Why?
|
Milk Proteins | 1 | 2004 | 161 | 0.010 |
Why?
|
STAT5 Transcription Factor | 1 | 2004 | 268 | 0.010 |
Why?
|
Primary Health Care | 1 | 2020 | 4746 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6792 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3706 | 0.010 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2003 | 130 | 0.010 |
Why?
|
STAT1 Transcription Factor | 1 | 2004 | 343 | 0.010 |
Why?
|
Perforin | 1 | 2003 | 167 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13668 | 0.010 |
Why?
|
Time Factors | 2 | 2019 | 40220 | 0.010 |
Why?
|
Chemokine CCL19 | 1 | 2002 | 37 | 0.010 |
Why?
|
Organ Specificity | 1 | 2007 | 1968 | 0.010 |
Why?
|
Chemokine CCL21 | 1 | 2002 | 49 | 0.010 |
Why?
|
Receptors, Interleukin | 1 | 2003 | 243 | 0.010 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2003 | 306 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 13045 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2002 | 510 | 0.010 |
Why?
|
Antibiotic Prophylaxis | 1 | 2007 | 640 | 0.010 |
Why?
|
Hybridomas | 1 | 2002 | 444 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 2004 | 693 | 0.010 |
Why?
|
Chemokines, CC | 1 | 2002 | 286 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65379 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 2 | 2000 | 1854 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2004 | 874 | 0.010 |
Why?
|
Tetanus Toxoid | 1 | 2000 | 188 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2003 | 1754 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2002 | 660 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2000 | 752 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 14164 | 0.010 |
Why?
|
Lymphatic System | 1 | 2000 | 251 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9527 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2002 | 1837 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 7876 | 0.010 |
Why?
|
Transgenes | 1 | 2000 | 1016 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41753 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2002 | 863 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1999 | 1627 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2002 | 1184 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 2002 | 1351 | 0.010 |
Why?
|
Chimera | 1 | 1997 | 454 | 0.010 |
Why?
|
Leukemia | 1 | 2003 | 1519 | 0.010 |
Why?
|
Trans-Activators | 1 | 2004 | 2857 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2003 | 3161 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2005 | 5902 | 0.010 |
Why?
|
Administration, Topical | 1 | 1997 | 704 | 0.010 |
Why?
|
Transfection | 1 | 2002 | 5756 | 0.010 |
Why?
|
Models, Animal | 1 | 2000 | 2122 | 0.010 |
Why?
|
Lymphoma | 1 | 2003 | 1898 | 0.010 |
Why?
|
Hybridization, Genetic | 1 | 1994 | 102 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2005 | 3474 | 0.010 |
Why?
|
Phosphorylation | 1 | 2004 | 8316 | 0.010 |
Why?
|
Cell Survival | 1 | 2003 | 5789 | 0.010 |
Why?
|
Down-Regulation | 1 | 2000 | 2939 | 0.010 |
Why?
|
Tissue Transplantation | 1 | 1994 | 128 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 1999 | 11095 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3713 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 30237 | 0.010 |
Why?
|
Liver | 1 | 2007 | 7578 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1997 | 1528 | 0.010 |
Why?
|
Cell Transplantation | 1 | 1994 | 475 | 0.010 |
Why?
|
Gene Expression | 1 | 2000 | 7601 | 0.000 |
Why?
|
Transplantation, Heterologous | 1 | 1994 | 2393 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1997 | 4568 | 0.000 |
Why?
|